Molecular Basis of Glioblastoma
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: closed (30 March 2021) | Viewed by 351
Special Issue Editors
Interests: personalized medicine; EGFRvIII; glioblastoma; GPCR in glioblastoma; osimertinib
Special Issue Information
The Cancer Genome Atlas (TCGA) has molecularly characterized a growing number of glioblastoma (GBM) samples and revealed that GBM is an extremely heterogeneous cancer. In this Special Issue, we will review the various subtypes of GBM and how these can be targeted. We will focus on four major areas: (1) EGFR heterogeneity; (2) NF1 abnormalities and mesenchymal signaling pathways; (3) PDGFRA and IDH1 mutations; (4) novel approaches for the treatment of GBM. This Special Issue will explore the molecular diversity of GBM and elucidate the research that needs to be undertaken to transform glioblastoma therapy.
Prof. Madan M. Kwatra
Prof. Glenn J. Lesser
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- GBM heterogeneity
- GBM stem cells
- targeting EGFR
- drug repurposing
- GPCR
